According to Zhen, the trial comparing nivolumab (Opdivo) plus chemotherapy vs chemotherapy alone led to an overall survival (OS) benefit in patients with a PD-L1 combined positive score (CPS) of 5 or ...

Different parts of Medicare can provide coverage for cancer treatments, including Opdivo. The coverage will depend on various factors, such as the phase of treatment and where a person receives ...

The biologics license application for RP1 (vusolimogene oderparepvec) plus nivolumab in advanced melanoma was accepted by the FDA with priority review. The FDA accepted the biologics license ...

Opdivo (nivolumab) is an immunotherapy treatment for advanced lung cancer or other cancers that have been resistant to other treatments. Though this is a newer drug, Medicare covers the cost of ...

The present meta-analysis aimed to explore the efficacy and safety of the combination of nivolumab and ipilimumab in treating GI cancers. Methods: A systematic search of four databases (PubMed, Embase ...